CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PharmaTimes
Original article

FairJourney Bio unveils tumor‑conditional IL‑12 breakthrough

tumor-conditional IL-12Positive
AI Analysis

Summary

FairJourney Bio announced a breakthrough in tumor-conditional IL-12 technology featuring a reversible switch mechanism for targeted cytokine delivery in cancer treatment.

Importance:5/10
Sentiment:
0.60
immunotherapycytokine deliverytumor-conditionalIL-12breakthrough

Read the original article

Published by PharmaTimes on August 25, 2026 9:08 AM

Read Original